These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21183903)

  • 1. [New approaches to the treatment of chronic daily headache].
    Naprienko MV; Latysheva NV; Filatova EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):33-8. PubMed ID: 21183903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of katadolon in the treatment of abuse headache].
    Naprienko MV; Filatova EG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(10):38-41. PubMed ID: 17117672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Headaches of tension and psychogenic headaches: assessment of the treatment with venlafaxine].
    Diukova GM; Toropina GG; Kovalchuk MO; Semenov RV; Troshneva A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3):37-41. PubMed ID: 20517224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-blind placebo run-in study of venlafaxine XR for activity-limiting osteoarthritis pain.
    Sullivan M; Bentley S; Fan MY; Gardner G
    Pain Med; 2009; 10(5):806-12. PubMed ID: 19496959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study.
    Yucel A; Ozyalcin S; Koknel Talu G; Kiziltan E; Yucel B; Andersen OK; Arendt-Nielsen L; Disci R
    Eur J Pain; 2005 Aug; 9(4):407-16. PubMed ID: 15979021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
    Montgomery SA; Huusom AK; Bothmer J
    Neuropsychobiology; 2004; 50(1):57-64. PubMed ID: 15179022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analgesic and muscle tonus normalizing effect of flupirtine retard in chronic back pain. Results of a standardized therapeutic evaluation applying objective methods for measuring pain pressure threshold, pain pressure tolerance and muscle tension].
    Müller-Schwefe GH; Uberall MA
    MMW Fortschr Med; 2008 Jan; 149 Suppl 4():153-61. PubMed ID: 18402240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
    Amr YM; Yousef AA
    Clin J Pain; 2010 Jun; 26(5):381-5. PubMed ID: 20473044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flupirtine in patients with cancer pain].
    Scheef W; Wolf-Gruber D
    Arzneimittelforschung; 1985; 35(1):75-7. PubMed ID: 3885963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis.
    Herrmann WM; Kern U; Aigner M
    Postgrad Med J; 1987; 63 Suppl 3():87-103. PubMed ID: 2451818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
    Cinciripini PM; Tsoh JY; Wetter DW; Lam C; de Moor C; Cinciripini L; Baile W; Anderson C; Minna JD
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):282-92. PubMed ID: 16366758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerance of flupirtine and pentazocine in two multicentre trials.
    Heusinger JH
    Postgrad Med J; 1987; 63 Suppl 3():71-9. PubMed ID: 2451817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute reduction of anandamide-hydrolase (FAAH) activity is coupled with a reduction of nociceptive pathways facilitation in medication-overuse headache subjects after withdrawal treatment.
    Perrotta A; Arce-Leal N; Tassorelli C; Gasperi V; Sances G; Blandini F; Serrao M; Bolla M; Pierelli F; Nappi G; Maccarrone M; Sandrini G
    Headache; 2012 Oct; 52(9):1350-61. PubMed ID: 22670561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valproic acid on withdrawal therapy in patients with overuse of chronic daily headache medications.
    Coskun O; Ucler S; Cavdar L; Inan LE
    J Clin Neurosci; 2007 Apr; 14(4):334-9. PubMed ID: 16647854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents.
    Olvera RL; Pliszka SR; Luh J; Tatum R
    J Child Adolesc Psychopharmacol; 1996; 6(4):241-50. PubMed ID: 9231317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The state of nociceptive and antinociceptive brain systems in patients with the pain form of diabetic polyneuropathy].
    Gordeev SA; Turbina LG; Zus'man AA; Posokhov SI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):23-7. PubMed ID: 22500308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mexiletine for refractory chronic daily headache: a report of nine cases.
    Marmura MJ; Passero FC; Young WB
    Headache; 2008; 48(10):1506-10. PubMed ID: 18793209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic daily headache: a scientist's perspective.
    Srikiatkhachorn A
    Headache; 2002 Jun; 42(6):532-7. PubMed ID: 12167146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic daily headache with medication overuse.
    Grazzi L; Andrasik F; D'Amico D; Usai S; Rigamonti A; Leone M; Bussone G
    Neurol Sci; 2003 May; 24 Suppl 2():S125-7. PubMed ID: 12811610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.